policy
publication date
Strategy
Northwell CEO Urging Healthcare Providers to Mobilize for Gun Control
The prominent executive is pushing beyond a letter he released last week and is now seeking to rally his peers...
Clinical Care
Prior Authorization Fixes Still a Medicare Priority, Says CMS Chief
Process needs to be less burdensome, Verma says
Strategy
HHS Drug Pricing Advisor to Depart
John O'Brien had replaced Dan Best after his predecessor's death in November 2018.
Providers Pan Trump Administration Final Rule on Public Charge
The 837-page expanded public charge rule limits who can get or keep a green card based on their use of...
Clinical Care
Nassar Abuse Fallout: MSU Agrees to Provide Chaperones During Sensitive Medical Exams
The healthcare entities associated with Michigan State University will adopt policies requiring a healthcare professional to serve as a chaperone...
Strategy
Hospitals Win Showdown With N.C. Treasurer Over Public Health Plan
The resulting hybrid network will include more than 68,000 healthcare providers, more than twice as many as had been in...
Strategy
New Illinois Law Makes Hospital Closures More Difficult
The new rules add administrative hurdles to the process by which hospital owners can close facilities or reduce services.
Finance
Healthcare Stocks, Dow Index Slide After Fed Cuts Rates
The Federal Reserve issued its first benchmark rate cut since 2008.
Strategy
Azar Outlines Drug Importation Plan After Reversing His Position
The breadth of the plan's impact will depend in large part on proposals brought forward by the industry.
Finance
Fresenius Posts 3% Revenue Growth, Net Income Falls 74%
The quarterly earnings were released three weeks after the Trump administration announced its new kidney initiative.
Strategy
'All Too Familiar': Judge Blocks N.H. Medicaid Work Requirements
The same federal judge has tossed out the Trump administration's approval of Medicaid work requirements in three states.
Finance
Senate Finance Committee Passes Bipartisan Drug Pricing Bill
The bipartisan drug pricing bill passed the committee but faces industry opposition and uncertainty in the full Senate.